Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-28

Clinical Trial Update: Cystatin C as a Marker for Detecting Early Renal Dysfunction in a Pediatric Emergency Department

View source ↗

Summary

A pediatric emergency department trial evaluated cystatin C as an early marker of renal dysfunction; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Hospital of Eastern Ontario | Conditions: Acute Renal Failure, Gastroenteritis | Status: COMPLETED